The cannabis-psychosis debate is being driven by fear mongering, not facts: Globe and Mail

One of the most debated health concerns regarding cannabis is its association with psychosis – particularly for young people. Frustratingly, both sides often resort to cherry picking data or confusing correlation with causation. Anecdotes, rather than science often prop up these arguments.

Not only does this misinformed understanding restrict patients who could potentially benefit from cannabinoid-based medicine’s effects, but as the authors explain, "By ignoring these important contexts, we are framing the onset of mental-health issues as a result of someone's personal choices, and thereby further perpetuating stigma around these conditions for individuals experiencing psychosis or with schizophrenia."

As the conversation continues, it is important to recognize the importance of research over an easy narrative; facts over fear-mongering.

Read full article here.